Normand Tremblay

C.Dir., M.Sc., C.Adm., C.M.C.

Co-founder and CEO

• Involved in this project since 2010. Full time with diaMentis since 2015
• Patented Medicine Prices Review Board (quasi-judicial tribunal)
  of Canada (PMPRB) member from 2012 to 2017
• Board member of the National Research Council of Canada (NRCC) from 2007 to 2010
• 100+ assignments in pharmaceutical market evaluations, feasibility studies, manufacturing planning, and commercial strategy as independent advisor
• Involved in creation or co-founder of 10 start-ups, of which several become listed (TSX/NASDAQ)
• Restructuring/interim CEO of 2 biotech companies on behalf
  of a PE/VC fund.
• Strategic Affairs/Investors Relations (1999-2004); Chief of Staff
  (1996-1999) Aeterna-Zentaris
• Teacher at University du Québec à Trois-Rivières (UQTR)
  Innovation & Management (MBA-MSc Program) 2009-2014.
• MSc in Drug Development Project Management from University du Québec à Trois-Rivières, Member of the l’Ordre des Administrateurs Agréés (C.Adm.) Certified Management Advisor (C.M.C.-Canada), Corporate Director (University Laval and McMaster University)